MENU
SMMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Summit Therapeutics (SMMT) Ownership - Who owns Summit Therapeutics?
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.2B
P/E Ratio
26.36
Total Cash
361.32M
Projected Growth
N/A
Total Debt
6.45M
Revenue
N/A
Risk (Beta)
-2.31
Dividend Yield
N/A
Total Cash/Share
0.49
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SMMT
Capitalization
19.2B
P/E Ratio
26.36
Risk (Beta)
-2.31
Dividend Yield
N/A
Total Cash
361M
Total Cash/Share
0.49
Total Debt
6.45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
344M
P/B Ratio
55.87
Cash Flow
N/A
Earnings
-0.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.42M
Current Ratio
10.63
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-235.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-85.89
Shares Held By Institutions
2.52B
Shares Outstanding - Current
743M
Total Liabilities
39.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
44.859
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com